E-LIB Suche - Ergebnisse für: Brauer, Dominic

1

Quantifying NPM1 MRD in AML patients prior to allogeneic st..:

Schwind, Sebastian ; Bischof, Lara ; Bill, Marius...
HemaSphere. 8 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

2

P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKE..:

Jentzsch, Madlen ; Bischof, Lara ; Ussmann, Jule...
HemaSphere. 7 (2023) S3 - p. e8583001 , 2023

Link: https://doi.org/10.1097/..

3

Clinical Implications of the FLT3-ITD Allelic Ratio in Acut..:

Jentzsch, Madlen ; Bischof, Lara ; Brauer, Dominic...
Cancers. 15 (2023) 4 - p. 1312 , 2023

Link: https://doi.org/10.3390/..

4

Prognostic impact of measurable residual clonal hematopoies..:

Bischof, Lara ; Ussmann, Jule ; Grimm, Juliane...
Leukemia. 38 (2023) 1 - p. 198-201 , 2023

Link: https://doi.org/10.1038/..

5

P508: THE PROGNOSTIC SIGNIFICANCE OF THE MEASURABLE RESIDUA..:

Bischof, Lara ; Ussmann, Jule ; Brauer, Dominic...
HemaSphere. 7 (2023) S3 - p. e1501256 , 2023

Link: https://doi.org/10.1097/..

6

Impact ofIDH1andIDH2mutation detection at diagnosis and in ..:

Bill, Marius ; Jentzsch, Madlen ; Bischof, Lara...
Blood Advances. 7 (2023) 3 - p. 436-444 , 2023

Link: https://doi.org/10.1182/..

7

PB2450: SEX-ASSOCIATED OUTCOME DIFFERENCES IN PATIENTS WITH..:

Ussmann, Jule ; Bischof, Lara ; Backhaus, Donata...
HemaSphere. 7 (2023) S3 - p. e6797913 , 2023

Link: https://doi.org/10.1097/..

8

A high hematopoietic cell transplantation comorbidity Index..:

Backhaus, Donata ; Brauer, Dominic ; Pointner, Rosmarie...
Bone Marrow Transplantation. 58 (2022) 1 - p. 30-38 , 2022

Link: https://doi.org/10.1038/..

9

Outcome prediction by the knowledge bank approach in acute ..:

Herrmann, Lisa ; Bischof, Lara ; Backhaus, Donata...
American Journal of Hematology. 97 (2022) 10 - p. , 2022

Link: https://doi.org/10.1002/..

10

Impact of MRD status in patients with AML undergoing alloge..:

Jentzsch, Madlen ; Bischof, Lara ; Backhaus, Donata...
Blood Advances. 6 (2022) 15 - p. 4570-4580 , 2022

Link: https://doi.org/10.1182/..

11

Prognostic impact of the AML ELN2022 risk classification in..:

Jentzsch, Madlen ; Bischof, Lara ; Ussmann, Jule...
Blood Cancer Journal. 12 (2022) 12 - p. , 2022

Link: https://doi.org/10.1038/..

12

Risk Stratification, Measurable Residual Disease, and Outco..:

Backhaus, Donata ; Jentzsch, Madlen ; Bischof, Lara...
Cancers. 13 (2021) 22 - p. 5679 , 2021

Link: https://doi.org/10.3390/..

13

Clinical implications of SRSF2 mutations in AML patients un..:

Grimm, Juliane ; Jentzsch, Madlen ; Bill, Marius...
American Journal of Hematology. 96 (2021) 10 - p. 1287-1294 , 2021

Link: https://doi.org/10.1002/..

14

Clinical value of the measurable residual disease status wi..:

Jentzsch, Madlen ; Grimm, Juliane ; Bill, Marius...
American Journal of Hematology. 96 (2021) 7 - p. , 2021

Link: https://doi.org/10.1002/..

15

Prognostic relevance of remission and measurable residual d..:

Jentzsch, Madlen ; Grimm, Juliane ; Bill, Marius...
Blood Cancer Journal. 11 (2021) 4 - p. , 2021

Link: https://doi.org/10.1038/..